Novel Synthetic and Natural Materials for Fighting the Global Challenge of Antimicrobial Resistance
A special issue of Materials (ISSN 1996-1944). This special issue belongs to the section "Advanced Nanomaterials and Nanotechnology".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 6383
Special Issue Editor
Interests: antibiotic resistance—mechanisms; epidemiology; reservoirs; antimicrobial strategies; microbial virulence and pathogenicity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
According to the 2016 World Bank Group Report, by 2050, the economic damage caused by drug-resistant infections could cause a 1.1% to 3.8% fall in the annual global GDP and global real exports, a healthcare cost increase of $300 billion to >$1 trillion/year, and a decrease in the global livestock production of 2.6%–7.5%/year, pushing up to 28 million people, mostly in developing countries, into poverty. As the market of nanomedicines is set to reach $400 billion by 2019, bionanomaterials could represent promising leads for developing new strategies to prevent, treat, and eradicate microbial infections produced by resistant pathogens. Nanobiomaterials could exhibit intrinsic antimicrobial activity, have additive or synergic effects with antibiotics or other antimicrobials, be used for drug delivery and targeted release to the site of infection, and prevent bacterial attachment and biofilm development. However, there is a huge discrepancy between the number of studies reporting the design of novel antimicrobial bio-nanomaterials and of those using in vivo models or including cytotoxicity assays for validating the respective bionanomaterials.
This Special Issue will present the current advances in developing novel antimicrobials, but also the challenges for translating them into clinical practice. In this regard, original research and review papers dealing with the physicochemical properties conditioning the antimicrobial activity of novel antimicrobials, including, but not limited to, nanomedicines, critical design criteria for the safe application of the novel antimicrobials, successful drug carriers and release system preparation, in vivo evaluation of the pharmacokinetic behavior of antimicrobials and analysis of their organ‐ and tissue‐level distribution, as well as nanomaterial modification for increasing their efficacy and biocompatibility are welcome.
Prof. Dr. Mariana Carmen ChifiriucGuest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Bacterial and fungal infections
- Antimicrobial resistance
- Antimicrobial and antiviral activity
- Bionanomaterials
- Drug delivery systems
- Bionanomedicines toxicology
- In vitro and in vivo models
- Biocompatibility
- Clinical studies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.